Russia Develops Cancer Vaccine Set to Launch in Early 2025

Andrey Kaprin was quoted by Russia’s state-financed agency, TASS, as the General Director of the Russian Ministry of Health’s Radiology Medical Research Centre. Alexander Gintsburg, the director of the Gamaleya National Research Centre for Epidemiology and Microbiology said that it has been tested on mice, demonstrating that the said vaccination can weaken tumour outcomes.

Read more: GSK Gets Positive Results for Type of Blood Cancer Drug Trial

President Vladimir Putin himself has likewise pointed out that Russian scientists are almost prepared to come up with cancer vaccines. He said in February, “We are very close to making what is called the cancer vaccines and the immunomodulatory new generation drugs.”

Even though the vaccine’s formal name and cancer types it targets are still unknown, other nations are investigating comparable developments. According to Newsweek, the British government has teamed with the German biotech business BioNTech to develop personalised cancer treatments. Gintsburg went on to say that artificial neural networks might dramatically shorten the process of generating personalised vaccines, potentially lowering it to less than one hour.

In parallel, pharmaceutical giants Moderna and Merck & Co are also working on their own experimental cancer vaccines. A mid-stage clinical trial of their vaccine indicated that it could reduce the risk of melanoma recurrence or death by 50% over a three-year period.

Stay tuned to Brandsynario for the latest news and updates.